Did Monopar Therapeutics MNPR insiders buy or sell in the past 90 days?

Stocks

Monopar Therapeutics MNPR

Health care sectorNasdaq

What to see in Monopar Therapeutics now

Is stock about to come to market?$3.9M

$3.9M of planned sales filed in 30 days · 0.7% of the units outstanding

Filed 10/01

Is Wall Street adding or cutting?+14

96 13F filers hold it · +14 against the quarter before · shares held −0.2%

Holdings of 06/30

Who bought more than 5%?4.7%

Saturn V Capital Management holds 4.7% · −0.5pp on the report before

Filed 08/12

Company

Exchange: Nasdaq
Sector: Health care
Industry: Pharmaceutical Preparations
Headquarters: Wilmette, Illinois
Fiscal year end: 12/31
Next earnings: 11/11, estimated

$3.9M of planned sales filed in 30 days · 0.7% of the units outstandingFiled 10/01
1 insiders, a net sale of $2.6M in 90 daysFiled 09/28

Insider trades

	Trade type
Chandler RobinsonChief Executive Officer	Open-market sale10b5-1 plan	09/24	09/28	10,450 sh	$87.15	$910,717.5	−8.1%
Chandler RobinsonChief Executive Officer	Open-market sale10b5-1 plan	09/24	09/28	9,638 sh	$87.96	$847,758.48	−8.2%
Chandler RobinsonChief Executive Officer	Open-market sale10b5-1 plan	09/24	09/28	8,368 sh	$88.97	$744,500.96	−7.7%
Chandler RobinsonChief Executive Officer	Open-market sale10b5-1 plan	09/24	09/28	600 sh	$89.79	$53,874	−0.6%
Quan Anh VuChief Financial Officer	Open-market buy	25/12/26	25/12/29	1,500 sh	$69.95	$104,925	No record

All insider trades in Monopar Therapeutics

Planned sales


Christopher M. StarrDirector	Monopar TherapeuticsMNPR10b5-1 plan	16,800 sh	$1,338,456	10/01	Filed 10/01
Chandler RobinsonDirector, Officer	Monopar TherapeuticsMNPR10b5-1 plan	29,056 sh	$2,597,025.28	09/24	Filed 09/24
Patrice RiouxActing Chief Medical Officer	Monopar TherapeuticsMNPR10b5-1 plan	1 sh	$110.82	08/26	Filed 08/26
Kim R. TsuchimotoDirector	Monopar TherapeuticsMNPR10b5-1 plan	8,180 sh	$906,507.6	08/26	Filed 08/26
Raymond AndersonDirector	Monopar TherapeuticsMNPR10b5-1 plan	6,284 sh	$699,786.24	08/25	Filed 08/25
Arthur J. KlausnerFormer Board Member	Monopar TherapeuticsMNPRAmendment	5,000 sh	$476,967	07/08	Filed 07/10
Arthur J. KlausnerEmployer	Monopar TherapeuticsMNPR	5,000 sh	$485,250	07/07	Filed 07/07
Arthur J. KlausnerBoard Member	Monopar TherapeuticsMNPR	5,121 sh	$343,903.47	25/12/18	Filed 25/12/19
Christopher M. StarrDirector	Monopar TherapeuticsMNPR	16,800 sh	$672,000	25/07/14	Filed 25/07/14
Kim R. TsuchimotoDirector	Monopar TherapeuticsMNPR	8,904 sh	$356,160	25/07/14	Filed 25/07/14

All planned sales of Monopar Therapeutics

26-week trading

No member of Congress reported a trade in Monopar Therapeutics MNPR in the past 90 days. Insiders filed 0 purchases and 4 sales on the open market over the same period, a net sale of $2.6M.

Common questions

Did Monopar Therapeutics MNPR insiders buy or sell in the past 90 days?: In the past 90 days insiders filed 0 purchases and 4 sales on the open market. Sales came to $2.6M.